Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Willingness to pay for prevention and treatment of lymphatic filariasis in Leogane, Haiti.

Identifieur interne : 003997 ( PubMed/Checkpoint ); précédent : 003996; suivant : 003998

Willingness to pay for prevention and treatment of lymphatic filariasis in Leogane, Haiti.

Auteurs : Richard D. Rheingans [États-Unis] ; Anne C. Haddix ; Mark L. Messonnier ; Martin Meltzer ; Gladys Mayard ; David G. Addiss

Source :

RBID : pubmed:14754463

Abstract

BACKGROUND: Lymphatic filariasis (LF) affects more than 120 million people worldwide. Efforts to eliminate this disease require sustained community participation. This study explores community valuation of LF elimination efforts by estimating household and community willingness to pay (WTP) for the prevention of transmission and treatment of filarial lymphedema in the community of Leogane, Haiti. METHODS: A contingent valuation survey was used to assess individual WTP for specific prevention and treatment interventions. A 2-dimensional Monte Carlo simulation was developed to estimate confidence limits in mean WTP and to generate a distribution of WTP for the community, accounting for uncertainty in regression coefficients and variability within the population. RESULTS: Mean WTP was estimated to be $5.57/month/household (95% CL: $4.76, $6.72) to prevent disease transmission, and $491/yr (95% CL: $377, $662) for treatment of lymphedema for one person. Based on the estimated distributions, 7% and 39% of households were not willing to pay for prevention and treatment, respectively. CONCLUSIONS: These results suggest that the majority of the community places a positive value on both prevention and treatment of LF. Mean WTP provides a useful monetary estimate of overall societal benefit of LF prevention and treatment programs. However, for interventions which require broad and sustained community participation, the lower end of the distribution of WTP has additional implications. Cost recovery policies may result in inadequate participation and longer program duration.

DOI: 10.1186/1475-2883-3-2
PubMed: 14754463


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:14754463

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Willingness to pay for prevention and treatment of lymphatic filariasis in Leogane, Haiti.</title>
<author>
<name sortKey="Rheingans, Richard D" sort="Rheingans, Richard D" uniqKey="Rheingans R" first="Richard D" last="Rheingans">Richard D. Rheingans</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of International Health, Rollins School of Public Health, Emory University, 1518 Clifton Rd, Atlanta, GA 30322 USA. rrheing@sph.emory.edu</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
</affiliation>
</author>
<author>
<name sortKey="Haddix, Anne C" sort="Haddix, Anne C" uniqKey="Haddix A" first="Anne C" last="Haddix">Anne C. Haddix</name>
</author>
<author>
<name sortKey="Messonnier, Mark L" sort="Messonnier, Mark L" uniqKey="Messonnier M" first="Mark L" last="Messonnier">Mark L. Messonnier</name>
</author>
<author>
<name sortKey="Meltzer, Martin" sort="Meltzer, Martin" uniqKey="Meltzer M" first="Martin" last="Meltzer">Martin Meltzer</name>
</author>
<author>
<name sortKey="Mayard, Gladys" sort="Mayard, Gladys" uniqKey="Mayard G" first="Gladys" last="Mayard">Gladys Mayard</name>
</author>
<author>
<name sortKey="Addiss, David G" sort="Addiss, David G" uniqKey="Addiss D" first="David G" last="Addiss">David G. Addiss</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:14754463</idno>
<idno type="pmid">14754463</idno>
<idno type="doi">10.1186/1475-2883-3-2</idno>
<idno type="wicri:Area/PubMed/Corpus">004084</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004084</idno>
<idno type="wicri:Area/PubMed/Curation">004084</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004084</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004084</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004084</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Willingness to pay for prevention and treatment of lymphatic filariasis in Leogane, Haiti.</title>
<author>
<name sortKey="Rheingans, Richard D" sort="Rheingans, Richard D" uniqKey="Rheingans R" first="Richard D" last="Rheingans">Richard D. Rheingans</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of International Health, Rollins School of Public Health, Emory University, 1518 Clifton Rd, Atlanta, GA 30322 USA. rrheing@sph.emory.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Géorgie (États-Unis)</region>
</placeName>
<wicri:cityArea>Department of International Health, Rollins School of Public Health, Emory University, 1518 Clifton Rd, Atlanta</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Haddix, Anne C" sort="Haddix, Anne C" uniqKey="Haddix A" first="Anne C" last="Haddix">Anne C. Haddix</name>
</author>
<author>
<name sortKey="Messonnier, Mark L" sort="Messonnier, Mark L" uniqKey="Messonnier M" first="Mark L" last="Messonnier">Mark L. Messonnier</name>
</author>
<author>
<name sortKey="Meltzer, Martin" sort="Meltzer, Martin" uniqKey="Meltzer M" first="Martin" last="Meltzer">Martin Meltzer</name>
</author>
<author>
<name sortKey="Mayard, Gladys" sort="Mayard, Gladys" uniqKey="Mayard G" first="Gladys" last="Mayard">Gladys Mayard</name>
</author>
<author>
<name sortKey="Addiss, David G" sort="Addiss, David G" uniqKey="Addiss D" first="David G" last="Addiss">David G. Addiss</name>
</author>
</analytic>
<series>
<title level="j">Filaria journal</title>
<idno type="ISSN">1475-2883</idno>
<imprint>
<date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">BACKGROUND: Lymphatic filariasis (LF) affects more than 120 million people worldwide. Efforts to eliminate this disease require sustained community participation. This study explores community valuation of LF elimination efforts by estimating household and community willingness to pay (WTP) for the prevention of transmission and treatment of filarial lymphedema in the community of Leogane, Haiti. METHODS: A contingent valuation survey was used to assess individual WTP for specific prevention and treatment interventions. A 2-dimensional Monte Carlo simulation was developed to estimate confidence limits in mean WTP and to generate a distribution of WTP for the community, accounting for uncertainty in regression coefficients and variability within the population. RESULTS: Mean WTP was estimated to be $5.57/month/household (95% CL: $4.76, $6.72) to prevent disease transmission, and $491/yr (95% CL: $377, $662) for treatment of lymphedema for one person. Based on the estimated distributions, 7% and 39% of households were not willing to pay for prevention and treatment, respectively. CONCLUSIONS: These results suggest that the majority of the community places a positive value on both prevention and treatment of LF. Mean WTP provides a useful monetary estimate of overall societal benefit of LF prevention and treatment programs. However, for interventions which require broad and sustained community participation, the lower end of the distribution of WTP has additional implications. Cost recovery policies may result in inadequate participation and longer program duration.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="Publisher" Owner="NLM">
<PMID Version="1">14754463</PMID>
<DateCreated>
<Year>2004</Year>
<Month>03</Month>
<Day>04</Day>
</DateCreated>
<DateRevised>
<Year>2017</Year>
<Month>02</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Print">1475-2883</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>3</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2004</Year>
<Month>Jan</Month>
<Day>30</Day>
</PubDate>
</JournalIssue>
<Title>Filaria journal</Title>
<ISOAbbreviation>Filaria J</ISOAbbreviation>
</Journal>
<ArticleTitle>Willingness to pay for prevention and treatment of lymphatic filariasis in Leogane, Haiti.</ArticleTitle>
<Pagination>
<MedlinePgn>2</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>BACKGROUND: Lymphatic filariasis (LF) affects more than 120 million people worldwide. Efforts to eliminate this disease require sustained community participation. This study explores community valuation of LF elimination efforts by estimating household and community willingness to pay (WTP) for the prevention of transmission and treatment of filarial lymphedema in the community of Leogane, Haiti. METHODS: A contingent valuation survey was used to assess individual WTP for specific prevention and treatment interventions. A 2-dimensional Monte Carlo simulation was developed to estimate confidence limits in mean WTP and to generate a distribution of WTP for the community, accounting for uncertainty in regression coefficients and variability within the population. RESULTS: Mean WTP was estimated to be $5.57/month/household (95% CL: $4.76, $6.72) to prevent disease transmission, and $491/yr (95% CL: $377, $662) for treatment of lymphedema for one person. Based on the estimated distributions, 7% and 39% of households were not willing to pay for prevention and treatment, respectively. CONCLUSIONS: These results suggest that the majority of the community places a positive value on both prevention and treatment of LF. Mean WTP provides a useful monetary estimate of overall societal benefit of LF prevention and treatment programs. However, for interventions which require broad and sustained community participation, the lower end of the distribution of WTP has additional implications. Cost recovery policies may result in inadequate participation and longer program duration.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rheingans</LastName>
<ForeName>Richard D</ForeName>
<Initials>RD</Initials>
<AffiliationInfo>
<Affiliation>Department of International Health, Rollins School of Public Health, Emory University, 1518 Clifton Rd, Atlanta, GA 30322 USA. rrheing@sph.emory.edu</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Haddix</LastName>
<ForeName>Anne C</ForeName>
<Initials>AC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Messonnier</LastName>
<ForeName>Mark L</ForeName>
<Initials>ML</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Meltzer</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mayard</LastName>
<ForeName>Gladys</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Addiss</LastName>
<ForeName>David G</ForeName>
<Initials>DG</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2004</Year>
<Month>01</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Filaria J</MedlineTA>
<NlmUniqueID>101147686</NlmUniqueID>
<ISSNLinking>1475-2883</ISSNLinking>
</MedlineJournalInfo>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Trop Med Int Health. 1998 Jun;3(6):467-73</RefSource>
<PMID Version="1">9657509</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trop Med Int Health. 1999 Jan;4(1):19-25</RefSource>
<PMID Version="1">10203169</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parasitol Today. 2000 Jul;16(7):298-302</RefSource>
<PMID Version="1">10858649</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Trop Med Hyg. 2001 Dec;65(6):865-71</RefSource>
<PMID Version="1">11791989</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Indian J Public Health. 1999 Apr-Jun;43(2):58-63</RefSource>
<PMID Version="1">11243067</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Trop Med Parasitol. 1996 Feb;90(1):39-48</RefSource>
<PMID Version="1">8729626</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Trop Med Hyg. 2003 May;68(5):568-73</RefSource>
<PMID Version="1">12812348</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Trop. 1993 Mar;53(1):1-26</RefSource>
<PMID Version="1">8096106</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Health Econ. 1998 Aug;17(4):475-97</RefSource>
<PMID Version="1">10180927</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trop Med Int Health. 1996 Aug;1(4):414-26</RefSource>
<PMID Version="1">8765447</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Wkly Epidemiol Rec. 2001 May 18;76(20):149-54</RefSource>
<PMID Version="1">11395916</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Indian J Med Res. 2000 Mar;111:81-9</RefSource>
<PMID Version="1">10937383</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parasitol Today. 2000 Jun;16(6):251-3</RefSource>
<PMID Version="1">10827432</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trans R Soc Trop Med Hyg. 2000 Nov-Dec;94(6):592-3</RefSource>
<PMID Version="1">11198636</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2003</Year>
<Month>06</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2004</Year>
<Month>01</Month>
<Day>30</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2004</Year>
<Month>2</Month>
<Day>3</Day>
<Hour>5</Hour>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2004</Year>
<Month>2</Month>
<Day>3</Day>
<Hour>5</Hour>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2004</Year>
<Month>2</Month>
<Day>3</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">14754463</ArticleId>
<ArticleId IdType="doi">10.1186/1475-2883-3-2</ArticleId>
<ArticleId IdType="pii">1475-2883-3-2</ArticleId>
<ArticleId IdType="pmc">PMC356926</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Géorgie (États-Unis)</li>
</region>
</list>
<tree>
<noCountry>
<name sortKey="Addiss, David G" sort="Addiss, David G" uniqKey="Addiss D" first="David G" last="Addiss">David G. Addiss</name>
<name sortKey="Haddix, Anne C" sort="Haddix, Anne C" uniqKey="Haddix A" first="Anne C" last="Haddix">Anne C. Haddix</name>
<name sortKey="Mayard, Gladys" sort="Mayard, Gladys" uniqKey="Mayard G" first="Gladys" last="Mayard">Gladys Mayard</name>
<name sortKey="Meltzer, Martin" sort="Meltzer, Martin" uniqKey="Meltzer M" first="Martin" last="Meltzer">Martin Meltzer</name>
<name sortKey="Messonnier, Mark L" sort="Messonnier, Mark L" uniqKey="Messonnier M" first="Mark L" last="Messonnier">Mark L. Messonnier</name>
</noCountry>
<country name="États-Unis">
<region name="Géorgie (États-Unis)">
<name sortKey="Rheingans, Richard D" sort="Rheingans, Richard D" uniqKey="Rheingans R" first="Richard D" last="Rheingans">Richard D. Rheingans</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003997 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 003997 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:14754463
   |texte=   Willingness to pay for prevention and treatment of lymphatic filariasis in Leogane, Haiti.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:14754463" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024